Phase II study of biweekly carboplatin and paclitaxel as first-line treatment for elderly patients with advanced non-small cell lung cancer.
H. Terai
No relevant relationships to disclose
K. Soejima
No relevant relationships to disclose
M. Nakamura
No relevant relationships to disclose
K. Naoki
No relevant relationships to disclose
H. Yasuda
No relevant relationships to disclose
R. Satomi
No relevant relationships to disclose
S. Nakayama
No relevant relationships to disclose
S. Yoda
No relevant relationships to disclose
S. Ikemura
No relevant relationships to disclose
T. Sato
No relevant relationships to disclose
K. Asano
No relevant relationships to disclose